Xing P - Search Results

1

[Analysis of the Correlation between Molecular Structural Differences of PD-1/PD-L1 Inhibitors and Adverse Events].

Xie T, Wang S, Xing P. Xie T, et al. Among authors: xing p. Zhongguo Fei Ai Za Zhi. 2020 Jul 20;23(7):603-608. doi: 10.3779/j.issn.1009-3419.2020.102.17. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32702794 Free PMC article. Review. Chinese.

2

[Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small cell lung cancer].

Xing P, Li J, Shi Y. Xing P, et al. Zhongguo Fei Ai Za Zhi. 2013 Oct 20;16(10):519-23. doi: 10.3779/j.issn.1009-3419.2013.10.04. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24113004 Free PMC article. Chinese.

3

[Treatment choice for advanced non-small cell lung cancer patients who had gradual progression after EGFR-TKIs: 32 cases report].

Lin L, Wang B, Hao X, Xing P, Li J, Zhang X, Shi Y. Lin L, et al. Among authors: xing p. Zhongguo Fei Ai Za Zhi. 2013 Oct 20;16(10):524-8. doi: 10.3779/j.issn.1009-3419.2013.10.05. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24113005 Free PMC article. Chinese.

4

[Clinical Analysis of 58 Patients with Small Cell Lung Cancer  Combined with Squamous Cell Cancer].

Luo Y, Men Y, Hui Z, Li J, Hao X, Xing P. Luo Y, et al. Among authors: xing p. Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):659-664. doi: 10.3779/j.issn.1009-3419.2016.10.04. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27760594 Free PMC article. Chinese.

5

[Recombinant Human Endostatin in the Treatment of Advanced Lung Squamous Cell Carcinoma].

Xing P, Hao X, Hu X, Wang Y, Li J. Xing P, et al. Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):670-674. doi: 10.3779/j.issn.1009-3419.2016.10.06. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27760596 Free PMC article. Chinese.

6

[Clinicopathologic Characteristics of the Patients in the Elderly Lung Carcinoma].

Chen J, Hao X, Cheng F, Zhang T, Xing P, Li J. Chen J, et al. Among authors: xing p. Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):675-678. doi: 10.3779/j.issn.1009-3419.2016.10.07. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27760597 Free PMC article. Chinese.

7

[Effects of Erlotinib on 34 Patients with Advanced Squamous Cell Lung Cancer].

Cheng F, Wang J, Chen J, Xing P, Li J. Cheng F, et al. Among authors: xing p. Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):679-681. doi: 10.3779/j.issn.1009-3419.2016.10.08. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27760598 Free PMC article. Chinese.

8

[Treatment of Advanced Squamous Cell Lung Cancer].

Zhu Y, Xing P, Li J. Zhu Y, et al. Among authors: xing p. Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):687-691. doi: 10.3779/j.issn.1009-3419.2016.10.10. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27760600 Free PMC article. Review. Chinese.

9

Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases.

Xing P, Wang S, Hao X, Zhang T, Li J. Xing P, et al. Oncotarget. 2016 Dec 20;7(51):84666-84674. doi: 10.18632/oncotarget.13179. Oncotarget. 2016. PMID: 27835868 Free PMC article.

10

Evaluation of calculating carboplatin dosage in carboplatin-pemetrexed therapy as the first-line therapy for Chinese patients with advanced lung adenocarcinoma.

Zhu Y, Xing P, Wang S, Ma D, Mu Y, Li X, Xu Z, Li J. Zhu Y, et al. Among authors: xing p. Thorac Cancer. 2018 Mar;9(3):400-407. doi: 10.1111/1759-7714.12594. Epub 2018 Jan 29. Thorac Cancer. 2018. PMID: 29377581 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

840 results

Search Page

Filters